Introduction
Transplantation is the best and, frequently, the only lifesaving treatment for end-stage organ failure. In 2014, 119 873 solid organ transplants were performed worldwide (World Health Organization Global Observatory on Organ Donation and Transplantation (1)). Although impressive, the annual number of organ transplants represents less than 10% of the global needs. Organ shortage leads to deaths and poor quality of life for those on the waiting list. Moreover, because the costs of renal replacement therapy with dialysis greatly surpass those of kidney transplantation after the first year, organ shortage implies important costs to healthcare systems. The benefits of transplantation have also been marred by the growing phenomenon of organ trafficking and transplant tourism, practices that violate fundamental human rights and threaten individual and public health.
The World Health Assembly, concerned by the growing demand for organs and exploitative actions against the destitute and vulnerable, urged member states "to strengthen national and multinational authorities and/or capacities to provide oversight, organization and coordination of donation and transplantation activities, with special attention to maximizing donation from deceased donors" (2) . Anticipating a call that the World Health Organization would launch 20 years later, the Spanish Ministry of Health created the Organizaci on Nacional de Trasplantes (ONT) in 1989 as an agency in charge of the coordination and oversight of donation, procurement, and transplantation activities in a politically decentralized country, albeit with an adequate legislative and technical framework from the transplantation perspective. The ONT conceived an organized and professionalized model to effectively identify donation opportunities and facilitate their transition to actual donation and to promote public support for donation after death (3) . The elements of the Spanish model, extensively described in literature, made Spain double its deceased donation activity in less than a decade ( Figure 1 ) and soon hold a privileged position worldwide that it maintains (4-6).
In 2008, Spain was confronted with important epidemiological events and changes in end-of-life care practices that challenged the progress of the country toward selfsufficiency in transplantation (7) . The ONT then designed the 40 donors per million population (pmp) plan (8) . The aims of this report are to summarize the challenges that the system has faced in further developing donation from the deceased and to describe the three strategies that have made Spain reach the target of 40 donors pmp 
Challenges for the Spanish Donation and Transplantation System
Despite the important transplant activity undertaken in the country, Spain is far from the self-sufficiency paradigm. The number of patients on the kidney waiting list remains above 4000, which exceeds the annual number of kidney transplantations carried out in the country (2500-3000), with preemptive transplantation being rare. From 6% to 8% of patients waiting for nonkidney transplants die every year, with a similar percentage being removed from the waiting list mainly because they have become too sick to be transplanted.
The chronic inability to cope with the transplantation needs of patients has been further challenged by important epidemiological changes and variations in the care of neurocritical patients. Mortality related to cerebrovascular and traffic accidents has fortunately decreased in Spain over the years, leading the country to hold one of the lowest mortality rates relevant to organ donation in the world (9) . The decrease in the occurrence of events potentially leading to devastating brain injuries as a result of transport and work safety measures, along with improvements in the treatment of neurocritical patients, explain such a decrease in mortality. The extended use of decompressive craniectomies and other neurosurgical interventions has also contributed to a progressive decline in the incidence of brain death, which has evolved from 65 cases pmp in 2001 to <50 pmp during the past years (10) .
Changes have also occurred in the patterns of care provided to critical patients at the end-of-life under the guidance of the relevant professional societies (11) . Far from what the Ethicus Study described for southern European countries at the beginning of the century, where deaths in the intensive care unit (ICU) following the withdrawal of life-sustaining therapy (WLST) were rare (12) , at present >30% of deaths in the Spanish ICUs and close to 20% of hospital deaths in patients with a devastating brain injury follow the decision to WLST because this is no longer in the best interest of the patient (13, 14) . Until recently, patients dying after the WLST could not be offered the opportunity to donate their organs, because the framework for the practice of controlled donation after circulatory death (cDCD) had not been developed and a moratorium existed on this particular activity since 1996 (15).
The 40 Donors pmp Population Plan
The situation described here prompted the system to consider new strategies to meet the demand of organs for transplantation and to ensure that the option of organ donation is posed in all circumstances of death. In 2008, Malta (n=8) Mexico (n=2960) Iceland (n=7) Colombia (n=1204) Costa Rica (n=127)
Uruguay (n=119) Brazil (n=7744) Estonia (n=49) Poland (n=1508) Latvia (n=79) ArgenƟna (n=1735) Iran (n=3370) Slovakia (n=245) Germany (n=3668) Belarus (n=438) Hungary (n=479) Lithuania (n=148) New Zealand (n=203)
Slovenia (n=111) Israel (n=433) Italy (n=3323) Ireland (n=266) Turkey (n=4552) Australia (n=1485) Switzerland (n=546) Finland (n=373) Denmark (n=392) Canada (n=2492) United Kingdom (n=4501)
Czech Republic (n=749)
Sweden (n=721) Netherlands (n=1263) Portugal (n=795) Norway (n=430) France (n=5523) Belgium (n=987)
Recipients of solid organs pmp
Recipients of organs from Deceased Donors pmp Recipients of organs from Living Donors pmp the ONT devised the 40 Donors pmp Plan, establishing this objective in deceased organ donation in all Spanish regions (8) . The objective was not arbitrary. When comparing performance between regions and hospitals, profound differences could be observed, not easily explained by disparities in the pool of possible donors (16) . These differences suggested that there was still considerable room for improvement.
Three specific objectives were established: (i) promote the early identification and referral of possible organ donors from outside of the ICU to consider elective nontherapeutic intensive care and incorporate the option of organ donation into end-of-life care; (ii) foster the use of expanded and nonstandard risk donors; and (iii) develop the framework for the practice of DCD. Actions undertaken to yield a level of activity that has been achieved by the country as a whole and surpassed by several Spanish regions are summarized next.
Promoting the identification and early referral of possible organ donors from outside of the ICU to consider elective non-therapeutic intensive care Early identification and referral of persons with a devastating brain injury in whom further treatment has been deemed futile by the treating team and who are considered possible organ donors-because of the likelihood of brain death within a short period of time-to pose the option of elective non-therapeutic intensive care to facilitate organ donation (ICOD) can substantially affect the pool of potential donation after brain death (DBD) donors (14) .
Some years ago, a group of Spanish hospitals had reached an outstanding performance in deceased donation, with rates over 60-70 donors pmp, levels that surpassed any previous assessment of the deceased donor potential in the country. However, former estimations of the DBD pool were exclusively focused on the ICU. Many factors determine the number of persons who die as a result of a devastating brain lesion within an ICU in conditions consistent with brain death, inclusive of endof-life care practices (17) . Admission criteria to the ICU and ICOD when intensive care is deemed futile are acknowledged as modifiable factors affecting the pool of donors, practices that are dependent on the level of professional knowledge and ownership of deceased donation.
In 2009, the ONT promoted a benchmarking study targeted to identify best-performing hospitals in the country in the different phases of the DBD process (18) . The study identified 10 hospitals with outstanding results in the identification and referral of possible organ donors from outside of the ICU to pose the option of ICOD. Qualitative questionnaires and on-site visits by external experts pointed out critical factors for successthese hospitals had devised a pathway of care of the neurocritical patient inclusive of the consideration of organ donation when the responsible team shifted from active treatment to palliative and end-of-life care. When prognosis was ominous and further treatment was deemed futile by the responsible physician, the case was referred to the donor coordinator and organ donation was discussed with the relatives along with the need to initiate/continue intensive care with the aim of incorporating the option of organ donation into the patient 0 s end-oflife care plans. This practice was a routine reflected in local protocols, well accepted and properly monitored. The finding was presented in the form of dedicated recommendations released to the Spanish network on the practice of ICOD as part of a Guide of Best Practices in Organ Donation (19) .
Further work focused on the quantitative and qualitative description of possible organ donors who were dying outside of the ICU in Spain. The first national assessment was performed in the context of a study jointly undertaken by the ONT and the Spanish Society of Emergency Care (Sociedad Española de Medicina de Urgencias y Emergencias). Possible organ donors accounted for one of 2000 patients attended at the emergency department of procurement hospitals. Of these possible donors admitted to the hospital through the emergency room, 69% died outside of the ICU (in the emergency department itself or on the hospital ward) with the possibility of organ donation not having been considered at any moment of their clinical evolution.
More recently, the ACCORD-Spain study assessed endof-life care practices relevant to organ donation at 68 hospitals in the country (14) . Information was collected from 1970 possible organ donors, of whom almost 40% were never admitted to the ICU during their hospital stay because the option of organ donation had not been considered when the responsible team had deemed further treatment futile. Notably, 43% of these patients were octogenarian and/or had significant comorbidities, and most were not ventilated at the moment when the decision was made not to continue intensive care. The study also pointed out some of the many challenges of ICOD-the complexity of conversations with the family, the frequent need for elective ventilation, the uncertainties about contraindications to organ donation that might become evident once the decision has been made to perform ICOD, and especially the difficulties of anticipating if brain death will occur within a reasonable period of time.
The practice of ICOD and its related challenges are now components of the national curriculum for donor coordinators and intensive and emergency care professionals in the framework of training activities organized and funded by the Spanish government. Jointly with SEMES, the ONT has produced recommendations on the role of emergency care professionals in organ donation (20) . A working group designated by the ONT and the Spanish Society of Intensive Care and Coronary Units (Sociedad Española de Medicina Intensiva y Unidades Coronarias) is now finalizing guidelines on ICOD for the intensive care community, targeted to harmonize and improve practices in this particular setting. The ONT is finally organizing Plan, Do, Study, Act cycles to promote the implementation of national recommendations on ICOD.
The costs of ICOD are covered by the public healthcare system. The practice provides more patients the opportunity of donating their organs, and it is considered costeffective. The use of ICU resources is limited in most cases-the median time between the devastating brain injury and death in patients admitted to the ICU to facilitate donation is 1 day in the Spanish experience (14) . It has been recently estimated that an ICU bed provided to a patient admitted to the ICU for palliation and consideration of organ donation results in 7.3 quality-adjusted lifeyears gained for the community per ICU bed-day (21).
Patients with devastating brain injury subject to ICOD are septuagenarian or octogenarian. Up to 40% will finally not transition to actual donation. However, the contribution of ICOD to actual donation rates is evident-it is estimated that 24% of actual organ donors in the country have been patients admitted to the ICU with the aim of incorporating organ donation into their end-of-life care pathway (14) .
Fostering the use of organs from expanded criteria and nonstandard risk donors Expanded criteria donors: In the context of the fortunate reduction in the number of deaths due to traffic accidents, if criteria for organ donation had remained unaltered, the deceased donation activity in Spain would have dramatically decreased. However, the Spanish coordination and transplantation system has progressively adopted more flexible criteria for donor selection. As a result, the number of aged donors, mostly dead as a result of cerebrovascular accidents, has sustainably increased in Spain. In 2015, >50% of deceased organ donors were aged ≥60 years, falling under the age criterion that defines the expanded criteria donor kidney used by the United Network for Organ Sharing. Moreover, 30% of deceased donors were older than 70 and 10% were older than 80 years ( Figure 3 ). An "old-for-old" allocation strategy has been devised from the beginning, whereby aged kidneys are preferentially allocated to aged recipients regardless of HLA mismatch, as also performed in other European programs (22) . As expected, the utilization rate (percentage of actual donors from whom at least one organ is transplanted) and the number of organs transplanted per donor for donors older than 60 years are reduced (80% and two organs transplanted per donor, respectively). However, these donors contribute to transplantation activities in a substantial manner-41% of the deceased kidney, 51% of the liver, and 24% of the lung transplant procedures are currently performed with organs recovered from donors within this age group. Discard rates of organs recovered from aged donors remain, however, high. Further analysis and work should lead the system to conclude whether organ discard is based on objective factors related to posttransplantation outcomes and to determine the role of, for example, ex vivo perfusion techniques in better assessing organ viability while allowing the reconditioning of organs.
Organ transplantation from aged deceased donors has been associated with suboptimal patient and graft survival. However, results are acceptable and the practice confers survival benefits compared with that of patients who remain on the waiting list. In a recent registry study undertaken in the region of Catalonia, 10-year deathcensored graft survival in recipients of kidneys from donors ≥75 years of age was 68%. More importantly, recipients of these kidneys had less than half the probability of death than their matched counterparts under dialysis therapy and waitlisted for kidney transplantation (23) .
Similarly, the use of livers from aged donors provides appropriate outcomes. Estimates of 1-and 5-year graft survival for recipients of livers from donors aged ≥75 years are 78% and 59%, respectively (24). Good results are especially obtained when applying strict donor selection criteria, and when avoiding the allocation of these livers into recipients with advanced liver disease (high MELD score) and with hepatitis C virus (HCV) cirrhosis (25) .
Nonstandard risk donors:
External audits of procurement hospitals in Spain have revealed that 25% of persons in a brain-dead condition are not considered medically suitable organ donors, although some of these medical contraindications are inappropriately established by the donor coordinator or the treating physician (10) . While safety of the process is an unquestionable professional standard, an evidence-based analysis of the risks should guide decisions on donor selection at a moment of organ shortage. The aging of the donor population is also inherently linked to progressively more difficult assessments of donor suitability.
The ONT has implemented a medical team available on a 24/7 basis for donor coordinators to ask for a second opinion regarding the medical suitability of potential organ donors. National Consensus Documents on the evaluation of organ donors to prevent the transmission of neoplasic diseases and with regard to infections have also been important elements in addressing the problem of inadequate donor losses on medical grounds (26, 27) . These documents have inspired recommendations on donor suitability at the Council of Europe level (28) . More recently, to clearly define the safety limits in the use of organs for transplantation, the ONT has developed a specific national registry on the prospective follow-up of recipients transplanted from nonstandard risk donors (i.e. history of malignancy or active infection). With complete follow-up available on 430 recipients of nonstandard risk donor organs, only one case of disease transmission has been reported. This was an anticipated transmission of a HCV infection from an anti-HCV-positive donor to an HCV-na€ ıve heart recipient in an urgent status. Information provided by this registry is contributing to increase the level of evidence that will guide future risk assessments in the evaluation of organ donors.
Developing the framework for the practice of donation after circulatory death Contrary to that described for other countries, DCD in Spain had been classically focused on Maastricht category II or uncontrolled DCD (uDCD) donors-persons who have been declared dead after an unsuccessfully resuscitated cardiac arrest. This particular type of DCD implies an important logistical effort, both inside and outside of the hospital, and a smooth cooperation between the different stakeholders involved (29) . Legal, ethical, and the aforementioned complexities have precluded many countries from embarking on this type of donation despite efforts to emulate this program in other realities (30) . Even within Spain, because of the degree of sophistication required, the activity was initially limited to three Spanish cities-A Coruña, Barcelona, and Madrid. Following national recommendations, and support by national and local authorities, other programs have been initiated, with a positive impact on the number of uDCD donors, although the activity has stabilized thereafter (Figure 1 ). At present, there are 11 uDCD programs in the country, yielding an important number of kidney transplants with impressive results (29) . Liver transplantation from uDCD donors has been made possible with a normothermic regional perfusion approach, which leads to reasonable outcomes close to those obtained with livers from DBD donors (29) . Results of lung transplantation from uDCD donors are also promising (29) . The contribution of ex vivo preservation strategies to the validation and repair of kidneys, livers, and lungs from uDCD donors is currently under study. cDCD had not been devised as an option in our country for many years. The aforementioned changes in end-oflife care were the main reason to reconsider the position of the country toward cDCD and eliminate the existing moratorium on its practice. A National Consensus Conference on DCD set down the basis for this practice in Spain and was followed by the development of new legislation that accommodated the possibility of cDCD and established the minimum requisites for its development (31, 32) . Along with institutional support and efforts in professional training and public education, the results of the initiative have been impressive (Figure 1) . Today, >50 hospitals in the country are embarked in cDCD, which already contributes to 10% of the overall deceased donation rates and has had a substantial impact on the kidney, but also the liver and lung transplantation activity, with excellent posttransplantation results so far (33, 34) . The experience with normothermic regional perfusion in the uDCD setting has been extended to cDCD in 12 centers. Spain will be able to address the question of whether normothermic regional perfusion confers advantages compared with the rapid recovery of organs in cDCD-in terms of number of organs available, posttransplantation survival, and incidence of ischemic cholangiopathy in the liver transplant setting.
Final Remarks and Conclusions
Organization around the process of deceased donation is the key for success of the Spanish system. This approach has been totally or partially replicated by other countries and regions, resulting in a progression in the pursuit of self-sufficiency in transplantation. The model can be indeed implemented in other realities as long as some basic conditions are guaranteed (35) . New challenges are being confronted by the system-the transplantation needs of the population are expected to increase, while the potential of donation might continue decreasing in the upcoming years, particularly for DBD. Novel strategies to adapt to this changing scenario, inclusive of ICOD, the use of organs from expanded and nonstandard risk donors and DCD are being explored and successfully implemented in Spain. This experience may inspire other countries to conceive new ways of dealing with the limited availability of deceased donor organs.
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